{"transactions":[{"id":738321,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series C Warrants","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The Series C Warrants have an exercise price equal to $3.14 per share of Common Stock or $3.139 per pre-funded warrant, are exercisable immediately, and will expire one year from the issuance date of the Series C Warrant."},{"field":"security","element":"securityTitle","label":"F5","text":"Under the terms of the Series B Warrants and the Series C Warrants, the Issuer may not effect the exercise of any portion thereof, and the JSB 2021 Trust will not have the right to exercise any portion thereof, which, upon giving effect to such exercise, would cause the JSB 2021 Trust (together with its affiliates) to own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. To the extent that exercise of the Series B Warrants or Series C Warrants will result in the JSB 2021 Trust (together with its affiliates) beneficially owning shares of Common Stock above such ownership limitations, the JSB 2021 Trust may exercise its Series B Warrants or Series C Warrants for pre-funded warrants to purchase shares of Common Stock, which pre-funded warrants will include a substantially similar maximum ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Series B Warrants and Series C Warrants are owned by the JSB 2021 Trust."}],"balance_after":955414,"derivative":{"exercise_price":3.14,"exercise_date":"2026-06-11","expiration_date":"2027-06-11","underlying":"Common Stock","underlying_shares":955414},"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":738320,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series B Warrants","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Series B Warrants have an exercise price equal to $3.32 per share of Common Stock or $3.319 per pre-funded warrant, are exercisable immediately, and will expire five years from the issuance date of the Series B Warrant."},{"field":"security","element":"securityTitle","label":"F5","text":"Under the terms of the Series B Warrants and the Series C Warrants, the Issuer may not effect the exercise of any portion thereof, and the JSB 2021 Trust will not have the right to exercise any portion thereof, which, upon giving effect to such exercise, would cause the JSB 2021 Trust (together with its affiliates) to own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. To the extent that exercise of the Series B Warrants or Series C Warrants will result in the JSB 2021 Trust (together with its affiliates) beneficially owning shares of Common Stock above such ownership limitations, the JSB 2021 Trust may exercise its Series B Warrants or Series C Warrants for pre-funded warrants to purchase shares of Common Stock, which pre-funded warrants will include a substantially similar maximum ownership limitation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Series B Warrants and Series C Warrants are owned by the JSB 2021 Trust."}],"balance_after":955414,"derivative":{"exercise_price":3.32,"exercise_date":"2026-06-11","expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":955414},"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":738319,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-06-15T21:37:36.000Z","date":"2026-06-11","kind":"purchase","planned":false,"acquired":true,"shares":955414,"price":3.14,"value":2999999.96,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 11, 2026, the Issuer completed a private placement (the \"Private Placement\") pursuant to a securities purchase agreement, dated June 9, 2026 (the \"Purchase Agreement\"), with the Joshua S. Boger 2021 Trust DTD 12/09/2021, of which the Reporting Person serves as the sole trustee (the \"JSB 2021 Trust\"), and certain accredited investors named therein. Pursuant to the Purchase Agreement, the JSB 2021 Trust purchased an aggregate of 955,414 units (the \"Units\"), each Unit comprised of (i) one share of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), (ii) one Series B warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series B Warrant\"), and (iii) one Series C warrant to purchase one share of Common Stock or a pre-funded warrant to purchase one share of Common Stock (each, a \"Series C Warrant\") for a purchase price of $3.14 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 1,600,117 shares of the Issuer's common stock held by the JSB 2021 Trust and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1795865,"source":{"system":"sec-edgar","filing":"0001437749-26-020691","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020691/rdgdoc.xml","form_type":"4"}},{"id":743658,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39785,"kind":"person","name":"ZAVRL FRANK","position":1,"cik":"0001652169","reported_name":"ZAVRL FRANK","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:45:09.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020217","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020217/rdgdoc.xml","form_type":"4"}},{"id":743657,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:44:43.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020216/rdgdoc.xml","form_type":"4"}},{"id":743656,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39783,"kind":"person","name":"Quigley David","position":1,"cik":"0002098754","reported_name":"Quigley David","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:44:17.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020215","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020215/rdgdoc.xml","form_type":"4"}},{"id":743655,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39782,"kind":"person","name":"Poulton Jeffrey V.","position":1,"cik":"0001782962","reported_name":"Poulton Jeffrey V.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:43:53.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020214","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020214/rdgdoc.xml","form_type":"4"}},{"id":743653,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:43:25.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020213","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020213/rdgdoc.xml","form_type":"4"}},{"id":743654,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:43:01.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020212","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020212/rdgdoc.xml","form_type":"4"}},{"id":743652,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:42:37.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020211","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020211/rdgdoc.xml","form_type":"4"}},{"id":743651,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:42:12.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020210","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020210/rdgdoc.xml","form_type":"4"}},{"id":905782,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66563,"kind":"person","name":"Winton Matthew","position":1,"cik":"0001971400","reported_name":"Winton Matthew","relationship":{"officer":true,"officer_title":"Chief Commercial and Business"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:02:27.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004168","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004168/rdgdoc.xml","form_type":"4"}},{"id":905781,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:02:01.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the President & Chief Executive Officer of the Issuer and a member of its Board of Directors. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":75000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-26-004167","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004167/rdgdoc.xml","form_type":"4"}},{"id":905780,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:01:35.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004166","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004166/rdgdoc.xml","form_type":"4"}},{"id":905779,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66561,"kind":"person","name":"De Rosch Mark","position":1,"cik":"0001890320","reported_name":"De Rosch Mark","relationship":{"officer":true,"officer_title":"EVP, RA and GA and PgM"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:01:12.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004165/rdgdoc.xml","form_type":"4"}},{"id":905778,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66560,"kind":"person","name":"Blackburn Kelly","position":1,"cik":"0001640575","reported_name":"Blackburn Kelly","relationship":{"officer":true,"officer_title":"EVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:00:47.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-004164","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004164/rdgdoc.xml","form_type":"4"}},{"id":905775,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:00:22.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":75000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-26-004162","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004162/rdgdoc.xml","form_type":"4"}},{"id":979425,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39783,"kind":"person","name":"Quigley David","position":1,"cik":"0002098754","reported_name":"Quigley David","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T23:16:27.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares granted pursuant to the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's board of directors. Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares granted pursuant to the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's board of directors. Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025."}],"balance_after":16200,"derivative":{"exercise_price":7.02,"expiration_date":"2035-10-27","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001437749-25-037054","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925037054/rdgdoc.xml","form_type":"4"}},{"id":994379,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66563,"kind":"person","name":"Winton Matthew","position":1,"cik":"0001971400","reported_name":"Winton Matthew","relationship":{"officer":true,"officer_title":"Chief Commercial and Business"}}],"security":"Common Stock","published_at":"2025-11-19T12:46:15.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":7.95,"value":11925.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001437749-25-035655","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035655/rdgdoc.xml","form_type":"4"}},{"id":994378,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66563,"kind":"person","name":"Winton Matthew","position":1,"cik":"0001971400","reported_name":"Winton Matthew","relationship":{"officer":true,"officer_title":"Chief Commercial and Business"}}],"security":"Common Stock","published_at":"2025-11-19T12:46:15.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":8.43,"value":29505.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001437749-25-035655","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035655/rdgdoc.xml","form_type":"4"}},{"id":994377,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-19T12:45:56.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10807,"price":8.46,"value":91427.22,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Shares held by the John J. Alam Roth IRA."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held by the John J. Alam Roth IRA."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the John J. Alam Roth IRA."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001437749-25-035654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035654/rdgdoc.xml","form_type":"4"}},{"id":994376,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-19T12:45:56.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10793,"price":8.46,"value":91308.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 1,471,578 hares held jointly by the Reporting Person and her spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the Sylvie Gregoire Roth IRA."}],"balance_after":1484078,"source":{"system":"sec-edgar","filing":"0001437749-25-035654","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035654/rdgdoc.xml","form_type":"4"}},{"id":994375,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:32.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":8.32,"value":20800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.26 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001437749-25-035653","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035653/rdgdoc.xml","form_type":"4"}},{"id":994374,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:32.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":8.45,"value":8450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-25-035653","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035653/rdgdoc.xml","form_type":"4"}},{"id":994373,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:08.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10793,"price":8.46,"value":91308.78,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001437749-25-035652","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035652/rdgdoc.xml","form_type":"4"}},{"id":994372,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:08.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10807,"price":8.46,"value":91427.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the John J. Alam Roth IRA."}],"balance_after":1484078,"source":{"system":"sec-edgar","filing":"0001437749-25-035652","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035652/rdgdoc.xml","form_type":"4"}},{"id":998168,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-17T14:02:21.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1693,"price":7.55,"value":12782.15,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1693,"source":{"system":"sec-edgar","filing":"0001437749-25-035310","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035310/rdgdoc.xml","form_type":"4"}},{"id":998167,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-17T14:02:21.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1707,"price":7.57,"value":12921.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held jointly by the Reporting Person and his spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1473285,"source":{"system":"sec-edgar","filing":"0001437749-25-035310","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035310/rdgdoc.xml","form_type":"4"}},{"id":998166,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-17T14:02:21.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":4447,"price":7.51,"value":33396.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held jointly by the Reporting Person and his spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors."}],"balance_after":1471578,"source":{"system":"sec-edgar","filing":"0001437749-25-035310","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035310/rdgdoc.xml","form_type":"4"}},{"id":998171,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1707,"price":7.57,"value":12921.99,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1707,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":998170,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1693,"price":7.55,"value":12782.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1473271,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":998169,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":4447,"price":7.51,"value":33396.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."}],"balance_after":1471578,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":998164,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66563,"kind":"person","name":"Winton Matthew","position":1,"cik":"0001971400","reported_name":"Winton Matthew","relationship":{"officer":true,"officer_title":"Chief Commercial and Business"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:17.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":7.57,"value":75700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.53 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-25-035308","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035308/rdgdoc.xml","form_type":"4"}},{"id":1000765,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-11-13T13:52:41.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":5553,"price":7.35,"value":40814.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held jointly by the Reporting Person and her spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors."}],"balance_after":1467131,"source":{"system":"sec-edgar","filing":"0001437749-25-034640","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925034640/rdgdoc.xml","form_type":"4"}},{"id":1000764,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T13:52:19.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":7.44,"value":26040.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001437749-25-034639","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925034639/rdgdoc.xml","form_type":"4"}},{"id":1000762,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-13T13:52:00.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":5553,"price":7.35,"value":40814.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."}],"balance_after":1467131,"source":{"system":"sec-edgar","filing":"0001437749-25-034638","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925034638/rdgdoc.xml","form_type":"4"}},{"id":1021696,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66563,"kind":"person","name":"Winton Matthew","position":1,"cik":"0001971400","reported_name":"Winton Matthew","relationship":{"officer":true,"officer_title":"Chief Commercial and Business"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-08T20:07:23.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares granted as an inducement award material to Dr. Winton's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025."}],"balance_after":75000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-10-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-25-030707","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925030707/rdgdoc.xml","form_type":"4"}},{"id":1101919,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:05:20.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021275","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021275/rdgdoc.xml","form_type":"4"}},{"id":1101918,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39785,"kind":"person","name":"ZAVRL FRANK","position":1,"cik":"0001652169","reported_name":"ZAVRL FRANK","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:04:25.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021274","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021274/rdgdoc.xml","form_type":"4"}},{"id":1101916,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:03:28.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021273","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021273/rdgdoc.xml","form_type":"4"}},{"id":1101917,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:02:45.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021272","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021272/rdgdoc.xml","form_type":"4"}},{"id":1101914,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39782,"kind":"person","name":"Poulton Jeffrey V.","position":1,"cik":"0001782962","reported_name":"Poulton Jeffrey V.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:01:55.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021271","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021271/rdgdoc.xml","form_type":"4"}},{"id":1101915,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:01:02.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021270","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021270/rdgdoc.xml","form_type":"4"}},{"id":1101912,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:00:16.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021269","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021269/rdgdoc.xml","form_type":"4"}},{"id":1149722,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO, GC & Secretary"}}],"security":"Common Stock","published_at":"2025-05-14T20:11:47.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":4233,"price":8.46,"value":35811.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average price of (i) 3,800 shares purchased at $8.4499 per share and (ii) 433 shares purchased at $8.5373 per share."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0001437749-25-016843","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925016843/rdgdoc.xml","form_type":"4"}},{"id":1268014,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:02:31.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the Chief Executive Officer of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":60000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-25-004076","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004076/rdgdoc.xml","form_type":"4"}},{"id":1268012,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO & GC"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:02:02.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":27000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001437749-25-004074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004074/rdgdoc.xml","form_type":"4"}},{"id":1268013,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:01:32.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":27000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001437749-25-004073","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004073/rdgdoc.xml","form_type":"4"}},{"id":1268011,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66560,"kind":"person","name":"Blackburn Kelly","position":1,"cik":"0001640575","reported_name":"Blackburn Kelly","relationship":{"officer":true,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:00:53.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":27000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001437749-25-004072","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004072/rdgdoc.xml","form_type":"4"}},{"id":1268010,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:00:23.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":60000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-25-004071","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004071/rdgdoc.xml","form_type":"4"}},{"id":1422252,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"CFO & GC"}}],"security":"Common Stock","published_at":"2024-08-27T20:09:50.000Z","date":"2024-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":18.16,"value":18160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares purchased in open-market transactions."}],"balance_after":1267,"source":{"system":"sec-edgar","filing":"0001437749-24-027848","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924027848/rdgdoc.xml","form_type":"4"}},{"id":1479594,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:28:19.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020414","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020414/rdgdoc.xml","form_type":"4"}},{"id":1479593,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:27:20.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020413","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020413/rdgdoc.xml","form_type":"4"}},{"id":1479592,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:23:50.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020412","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020412/rdgdoc.xml","form_type":"4"}},{"id":1479591,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:22:41.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020411","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020411/rdgdoc.xml","form_type":"4"}},{"id":1479590,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39782,"kind":"person","name":"Poulton Jeffrey V.","position":1,"cik":"0001782962","reported_name":"Poulton Jeffrey V.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:21:32.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020410","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020410/rdgdoc.xml","form_type":"4"}},{"id":1479589,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:20:01.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020409","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020409/rdgdoc.xml","form_type":"4"}},{"id":1479588,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39785,"kind":"person","name":"ZAVRL FRANK","position":1,"cik":"0001652169","reported_name":"ZAVRL FRANK","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:19:15.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020408","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020408/rdgdoc.xml","form_type":"4"}},{"id":1613067,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Common Stock Purchase Warrant","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"other","planned":false,"acquired":false,"shares":495995,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":495995},"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1613066,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":36,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":840451,"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1613065,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-02-28T22:02:49.000Z","date":"2024-02-26","kind":"other","planned":false,"acquired":true,"shares":495995,"ownership":{"direct":false,"nature":"By Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the \"Pre-Funded Warrant\") held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the \"JSB 2021 Trust\") and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the \"ASB 2021 Trust\"). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":840487,"source":{"system":"sec-edgar","filing":"0001437749-24-005918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924005918/rdgdoc.xml","form_type":"4"}},{"id":1646970,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":16177,"kind":"person","name":"BOGER JOSHUA S","position":1,"cik":"0001197023","reported_name":"BOGER JOSHUA S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-13T21:39:58.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 12, 2024, in connection with the Reporting Person's initial election to the Issuer's board of directors, the Reporting Person was granted an option to purchase 10,000 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a three-year period in substantially equal 1/36th increments on the last day of each month beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":13.97,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-003927","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924003927/rdgdoc.xml","form_type":"4"}},{"id":1669919,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:47:52.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":35500,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-24-002349","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002349/rdgdoc.xml","form_type":"4"}},{"id":1669918,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66560,"kind":"person","name":"Blackburn Kelly","position":1,"cik":"0001640575","reported_name":"Blackburn Kelly","relationship":{"officer":true,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:46:57.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":16000,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-24-002348","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002348/rdgdoc.xml","form_type":"4"}},{"id":1669917,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":94885,"kind":"person","name":"TANNER JOHN WILLIAM","position":1,"cik":"0001990356","reported_name":"TANNER JOHN WILLIAM","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:46:09.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":16000,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-24-002347","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002347/rdgdoc.xml","form_type":"4"}},{"id":1669916,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:45:30.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":16000,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-24-002346","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002346/rdgdoc.xml","form_type":"4"}},{"id":1669915,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:44:26.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the Chief Executive Officer of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":35500,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-24-002345","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002345/rdgdoc.xml","form_type":"4"}},{"id":1669914,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:43:25.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":55721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":55721,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":55721},"source":{"system":"sec-edgar","filing":"0001437749-24-002344","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002344/rdgdoc.xml","form_type":"4"}},{"id":1731686,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":94885,"kind":"person","name":"TANNER JOHN WILLIAM","position":1,"cik":"0001990356","reported_name":"TANNER JOHN WILLIAM","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T21:05:52.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 20, 2023, the Reporting Person was granted an option to purchase 32,000 shares of the Issuer's common stock in accordance with the terms of the Employment Agreement, dated November 15, 2023, by and between the Reporting Person and the Issuer; provided, however, that the Reporting Person's continued holding of the grant is contingent upon the annual automatic increase in the number of shares available for issuance under the Issuer's 2015 Equity Incentive Plan, as amended (the \"Plan\") on January 1, 2024 pursuant to Section 4.1 of the Plan (together with any other shares available for issuance under the Plan as of such date) being sufficient to cover all shares of the Issuer's common stock underlying the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the conditions described in Note 1, 1/24 of the shares underlying the option grant will vest on January 1, 2024, and thereafter the award will vest in substantially equal 1/36th increments on the last day of each month, commencing January 31, 2024, through the last day of the month containing the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date."}],"balance_after":32000,"derivative":{"exercise_price":9.82,"expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001437749-23-032892","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923032892/rdgdoc.xml","form_type":"4"}},{"id":1745989,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-11-10T00:41:32.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents one or more bona fide gifts of the Issuer's Common Stock by the Reporting Person (such shares, the \"Gift Shares\") to certain friends and/or family members who are not immediate family members sharing the same household.  In accordance with the terms of the lock-up agreement, dated March 30, 2023, by and between the Reporting Person and the Issuer (the \"Lock-Up Agreement\"), in connection with the transfer(s) of the Gift Shares, each transferee will be subject to an agreement pursuant to which the transferee agrees not to further transfer the Gift Shares prior to August 16, 2024, subject to certain exceptions, on terms substantially similar to those set forth in the Lock-Up Agreement. Following the transaction, the Reporting Person has neither investment control over nor a pecuniary interest in the Gift Shares."}],"balance_after":732039,"source":{"system":"sec-edgar","filing":"0001437749-23-031330","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923031330/rdgdoc.xml","form_type":"4"}},{"id":1745988,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-11-10T00:41:03.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents one or more bona fide gifts of the Issuer's Common Stock by the Reporting Person (such shares, the \"Gift Shares\") to certain friends and/or family members who are not immediate family members sharing the same household.  In accordance with the terms of the lock-up agreement, dated March 30, 2023, by and between the Reporting Person and the Issuer (the \"Lock-Up Agreement\"), in connection with the transfer(s) of the Gift Shares, each transferee will be subject to an agreement pursuant to which the transferee agrees not to further transfer the Gift Shares prior to August 16, 2024, subject to certain exceptions, on terms substantially similar to those set forth in the Lock-Up Agreement. Following the transaction, the Reporting Person has neither investment control over nor a pecuniary interest in the Gift Shares."}],"balance_after":729539,"source":{"system":"sec-edgar","filing":"0001437749-23-031329","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923031329/rdgdoc.xml","form_type":"4"}},{"id":1780426,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T23:02:02.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026079","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026079/rdgdoc.xml","form_type":"4"}},{"id":1780425,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":94885,"kind":"person","name":"TANNER JOHN WILLIAM","position":1,"cik":"0001990356","reported_name":"TANNER JOHN WILLIAM","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:55:05.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2023-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026077","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026077/rdgdoc.xml","form_type":"4"}},{"id":1780424,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:54:37.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026076","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026076/rdgdoc.xml","form_type":"4"}},{"id":1780423,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:54:37.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":35500,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-23-026076","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026076/rdgdoc.xml","form_type":"4"}},{"id":1780422,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39785,"kind":"person","name":"ZAVRL FRANK","position":1,"cik":"0001652169","reported_name":"ZAVRL FRANK","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:53:58.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026075","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026075/rdgdoc.xml","form_type":"4"}},{"id":1780421,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:53:26.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026074/rdgdoc.xml","form_type":"4"}},{"id":1780420,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39782,"kind":"person","name":"Poulton Jeffrey V.","position":1,"cik":"0001782962","reported_name":"Poulton Jeffrey V.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:52:55.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026073","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026073/rdgdoc.xml","form_type":"4"}},{"id":1780419,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:52:19.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026072","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026072/rdgdoc.xml","form_type":"4"}},{"id":1780418,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:51:44.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option to purchase shares of common stock granted to John Alam, M.D., the Reporting Person's spouse and the Chief Executive Officer of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":35500,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-23-026071","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026071/rdgdoc.xml","form_type":"4"}},{"id":1780417,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39781,"kind":"person","name":"Gregoire Sylvie","position":1,"cik":"0001335822","reported_name":"Gregoire Sylvie","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:51:44.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026071","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026071/rdgdoc.xml","form_type":"4"}},{"id":1780415,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66562,"kind":"person","name":"ELDER WILLIAM ROBERT","position":1,"cik":"0001828068","reported_name":"ELDER WILLIAM ROBERT","relationship":{"officer":true,"officer_title":"GC & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:51:10.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026070","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026070/rdgdoc.xml","form_type":"4"}},{"id":1780416,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":109687,"kind":"person","name":"DAVIDSON JILL","position":1,"cik":"0001989900","reported_name":"DAVIDSON JILL","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:50:32.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026069","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026069/rdgdoc.xml","form_type":"4"}},{"id":1780414,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":66560,"kind":"person","name":"Blackburn Kelly","position":1,"cik":"0001640575","reported_name":"Blackburn Kelly","relationship":{"officer":true,"officer_title":"VP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:49:51.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026068","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026068/rdgdoc.xml","form_type":"4"}},{"id":1787730,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":122},"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1787729,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":898,"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1787728,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:31:04.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":122,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 77 Shares and (ii) $266.40 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.92.  The award is now fully vested."}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0001437749-23-025311","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923025311/rdgdoc.xml","form_type":"4"}},{"id":1837348,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-07-05T21:30:37.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":928,"derivative":{"underlying":"Common Stock","underlying_shares":232},"source":{"system":"sec-edgar","filing":"0001437749-23-019395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923019395/rdgdoc.xml","form_type":"4"}},{"id":1837347,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-05T21:30:37.000Z","date":"2023-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":294,"source":{"system":"sec-edgar","filing":"0001437749-23-019395","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923019395/rdgdoc.xml","form_type":"4"}},{"id":1837346,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-05T21:30:37.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 147 Shares and (ii) $283.90 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.34.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":379,"source":{"system":"sec-edgar","filing":"0001437749-23-019395","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923019395/rdgdoc.xml","form_type":"4"}},{"id":1870661,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":183,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1870660,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1231,"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1870659,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T21:00:28.000Z","date":"2023-05-31","kind":"exercise","planned":false,"acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $263.84 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $3.88.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1299,"source":{"system":"sec-edgar","filing":"0001437749-23-016502","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923016502/rdgdoc.xml","form_type":"4"}},{"id":1932876,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-04-03T21:49:42.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1160,"derivative":{"underlying":"Common Stock","underlying_shares":232},"source":{"system":"sec-edgar","filing":"0001437749-23-009126","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923009126/rdgdoc.xml","form_type":"4"}},{"id":1932875,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-03T21:49:42.000Z","date":"2023-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":147,"source":{"system":"sec-edgar","filing":"0001437749-23-009126","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923009126/rdgdoc.xml","form_type":"4"}},{"id":1932874,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":111643,"kind":"person","name":"LANCHONEY DIANA M","position":1,"cik":"0001887450","reported_name":"LANCHONEY DIANA M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-03T21:49:42.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) [147] Shares and (ii) $352.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.15.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":232,"source":{"system":"sec-edgar","filing":"0001437749-23-009126","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923009126/rdgdoc.xml","form_type":"4"}},{"id":1975469,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":366,"derivative":{"underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":1975468,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"disposition_to_issuer","acquired":false,"shares":68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1116,"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":1975467,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39780,"kind":"person","name":"Hollingsworth Jane H","position":1,"cik":"0001297141","reported_name":"Hollingsworth Jane H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-03T23:20:25.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":183,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 28, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1184,"source":{"system":"sec-edgar","filing":"0001437749-23-005435","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923005435/rdgdoc.xml","form_type":"4"}},{"id":2033800,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-03T21:13:40.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001437749-23-002473","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923002473/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2023-02-03T21:13:40.000000Z,2033800"}